Moderna Inc (MRNA)
$122.50
1.36 (1.12%)
MRNA Stock Quote Delayed 30 Minutes
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
46.92B
PE Ratio
-7.82
EPS
-15.66
Volume (Avg. Vol.)
921,875
Day's Range
$120.44 - $124.06
52-Week Range
$62.55 - $170.47
Dividend & Yield
N/A (N/A)
MRNA Stock Predictions, Articles, and Moderna Inc News
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
Vaccine stocks are taking it on the chin following President Biden's comments that the "pandemic is over." What now?
7 Growth Stocks That Could 10X by 2027
It takes courage and conviction right now to snap up growth stocks to buy that could appreciate 10-fold over the next five years.
PFE, MRNA Stocks: What to Know as the FDA Approves New Booster Shots
Pfizer (PFE) and Moderna (MRNA) stocks are in the news Wednesday as the FDA approves new booster shots for the Covid-19 omicron variant.
MRNA Stock Alert: What to Know as U.K. Approves Updated Moderna Booster
As the medical community marks a potentially momentous event in the fight against Covid-19, MRNA stock is making a move to the upside.
Moderna (MRNA) Stock Pops on Strong Sales, Earnings Beat
Moderna (MRNA) stock is rising on Wednesday as the Covid-19 vaccine company reports earnings for the second quarter of 2022.
The CDC Just Gave Novavax (NVAX) Stock a Big Boost
Novavax stock is up 6% today after the U.S. Centers for Disease Control and Prevention (CDC) approved its two-dose Covid-19 vaccine for use in adults.
What Is Going on With Novavax (NVAX) Stock Today?
NVAX stock is falling on news that European regulators have placed a new warning on the company's Covid-19 vaccine.
MRNA Stock Forecast: 3 Analysts Predict Where Moderna Will Go From Here
Moderna (MRNA) stock is in the spotlight today as investors react to news of a new vaccine for Covid-19 that works on omicron.
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.
Moderna Stock Looks Strong as the World Needs More Vaccines
A fresh viral outbreak is a cause for concern, but Moderna's already developing a potential vaccine and MRNA stock could benefit from this.
